Trial Outcomes & Findings for Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty (NCT NCT03859024)
NCT ID: NCT03859024
Last Updated: 2024-09-19
Results Overview
Self-report via pain score on the Numerical Rating Scale (NRS) for pain, an 11-point scale for patient self-reporting of pain. A rating of 0 equates to no pain, 1-3 equates to mild pain, 4-6 equates to moderate pain, and 7-10 equates to severe pain. Assessment will occur at clinic visit, at pre-op visit, in pre-op holding before surgery, per anesthesia protocol after surgery in recovery and discharge unit, and at postoperative visit
COMPLETED
PHASE4
48 participants
3 weeks
2024-09-19
Participant Flow
Participant milestones
| Measure |
Standard Protocol
Patients will receive the historical standard for pain management, which may include narcotics during and after surgery. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed.
Oxycodone: oxycodone tablet
Acetaminophen: acetaminophen tablet
Ibuprofen 800 mg: ibuprofen tablet
|
Enhanced Recovery Protocol
A combination regimen of acetaminophen, Celebrex and gabapentin pre-op, with 30 mL of 0.5% bupivacaine and 4 mg of dexamethasone given as a perineal nerve block at the time of urethroplasty surgery. Narcotics will be administered judiciously and ass seen fit by the anesthesia and/or surgical teams. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed.
Oxycodone: oxycodone tablet
Acetaminophen: acetaminophen tablet
Gabapentin: gabapentin tablet
celebrex: Celebrex tablet
Bupivacaine: bupivacaine injection
Ibuprofen 800 mg: ibuprofen tablet
Dexamethasone: Dexamethasone injection
|
|---|---|---|
|
Overall Study
STARTED
|
23
|
25
|
|
Overall Study
COMPLETED
|
23
|
24
|
|
Overall Study
NOT COMPLETED
|
0
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Standard Protocol
n=23 Participants
Patients will receive the historical standard for pain management, which may include narcotics during and after surgery. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed.
Oxycodone: oxycodone tablet
Acetaminophen: acetaminophen tablet
Ibuprofen 800 mg: ibuprofen tablet
|
Enhanced Recovery Protocol
n=25 Participants
A combination regimen of acetaminophen, Celebrex and gabapentin pre-op, with 30 mL of 0.5% bupivacaine and 4 mg of dexamethasone given as a perineal nerve block at the time of urethroplasty surgery. Narcotics will be administered judiciously and ass seen fit by the anesthesia and/or surgical teams. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed.
Oxycodone: oxycodone tablet
Acetaminophen: acetaminophen tablet
Gabapentin: gabapentin tablet
celebrex: Celebrex tablet
Bupivacaine: bupivacaine injection
Ibuprofen 800 mg: ibuprofen tablet
Dexamethasone: Dexamethasone injection
|
Total
n=48 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=23 Participants
|
0 Participants
n=25 Participants
|
0 Participants
n=48 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
20 Participants
n=23 Participants
|
21 Participants
n=25 Participants
|
41 Participants
n=48 Participants
|
|
Age, Categorical
>=65 years
|
3 Participants
n=23 Participants
|
4 Participants
n=25 Participants
|
7 Participants
n=48 Participants
|
|
Age, Continuous
|
50 years
n=23 Participants
|
50 years
n=25 Participants
|
50 years
n=48 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=23 Participants
|
0 Participants
n=25 Participants
|
0 Participants
n=48 Participants
|
|
Sex: Female, Male
Male
|
23 Participants
n=23 Participants
|
25 Participants
n=25 Participants
|
48 Participants
n=48 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
23 participants
n=23 Participants
|
25 participants
n=25 Participants
|
48 participants
n=48 Participants
|
PRIMARY outcome
Timeframe: 3 weeksSelf-report via pain score on the Numerical Rating Scale (NRS) for pain, an 11-point scale for patient self-reporting of pain. A rating of 0 equates to no pain, 1-3 equates to mild pain, 4-6 equates to moderate pain, and 7-10 equates to severe pain. Assessment will occur at clinic visit, at pre-op visit, in pre-op holding before surgery, per anesthesia protocol after surgery in recovery and discharge unit, and at postoperative visit
Outcome measures
| Measure |
Standard Protocol
n=23 Participants
Patients will receive the historical standard for pain management, which may include narcotics during and after surgery. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed.
Oxycodone: oxycodone tablet
Acetaminophen: acetaminophen tablet
Ibuprofen 800 mg: ibuprofen tablet
|
Enhanced Recovery Protocol
n=24 Participants
A combination regimen of acetaminophen, Celebrex and gabapentin pre-op, with 30 mL of 0.5% bupivacaine and 4 mg of dexamethasone given as a perineal nerve block at the time of urethroplasty surgery. Narcotics will be administered judiciously and ass seen fit by the anesthesia and/or surgical teams. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed.
Oxycodone: oxycodone tablet
Acetaminophen: acetaminophen tablet
Gabapentin: gabapentin tablet
celebrex: Celebrex tablet
Bupivacaine: bupivacaine injection
Ibuprofen 800 mg: ibuprofen tablet
Dexamethasone: Dexamethasone injection
|
|---|---|---|
|
Participant Pain Control: Numerical Rating Scale (NRS)
|
1.2 score on a scale
Interval 0.0 to 10.0
|
.625 score on a scale
Interval 0.0 to 10.0
|
PRIMARY outcome
Timeframe: 3 weeksAmount of opioid medication used, based on return pill count at postoperative visit.
Outcome measures
| Measure |
Standard Protocol
n=23 Participants
Patients will receive the historical standard for pain management, which may include narcotics during and after surgery. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed.
Oxycodone: oxycodone tablet
Acetaminophen: acetaminophen tablet
Ibuprofen 800 mg: ibuprofen tablet
|
Enhanced Recovery Protocol
n=24 Participants
A combination regimen of acetaminophen, Celebrex and gabapentin pre-op, with 30 mL of 0.5% bupivacaine and 4 mg of dexamethasone given as a perineal nerve block at the time of urethroplasty surgery. Narcotics will be administered judiciously and ass seen fit by the anesthesia and/or surgical teams. Postoperative prescriptions ibuprofen 800 mg, and acetaminophen 1000 mg to be taken on a scheduled basis then as needed. Another prescription for oxycodone will be given to be used only if needed.
Oxycodone: oxycodone tablet
Acetaminophen: acetaminophen tablet
Gabapentin: gabapentin tablet
celebrex: Celebrex tablet
Bupivacaine: bupivacaine injection
Ibuprofen 800 mg: ibuprofen tablet
Dexamethasone: Dexamethasone injection
|
|---|---|---|
|
Opioid Medication Use
|
5.14 pill count
Interval 0.0 to 14.0
|
4.96 pill count
Interval 0.0 to 14.0
|
Adverse Events
Standard Protocol
Enhanced Recovery Protocol
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Adam Baumgarten
University of Alabama at Birmingham
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place